» Articles » PMID: 15366758

Galen on Obesity: Etiology, Effects, and Treatment

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2004 Sep 16
PMID 15366758
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Only a few studies have been conducted to determine the historical background of obesity, and even fewer have focused on specific writers who have made great contributions on the subject. Galen was among the first to establish scientific methods to describe and treat morbid obesity, and a presentation of his ideas is important because of the influence he has exerted even up to modern times. The methodology of the current research was based on detailed study of Galen's treatises, which concern the nature of obesity, the etiology, the consequences, and the treatment, often in comparison to the writings of other writers from the Hippocratic period up to recent years. Galen stated that obesity results from the surplus of "bad humors" in the body and specifically from a surplus of blood. He specifically described patients' conditions, both physiologic and practical; he presented side effects; and he introduced methods of treatment that are used even today. Galen also described an illness he called polisarkia, which today we call morbid obesity. According to Galen's views, we can identify morbid obesity under the description of polisarkia. Galenic physiology and pathology have been proved wrong and have been set aside. Nevertheless, he proposed some treatments for obesity such as diet, exercise, and medications that are still valuable and are nearly the same as what is advocated today.

Citing Articles

Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?.

Singh S, Sudhamshu K, Anirvan P, Shrestha A, Al Mahtab M Euroasian J Hepatogastroenterol. 2024; 14(1):1-4.

PMID: 39022204 PMC: 11249896. DOI: 10.5005/jp-journals-10018-1424.


Obesity from a sign of being rich to a disease of the new age: A historical review.

Marghoub S, Sanaie S, Sullman M, Nejadghaderi S, Safiri S, Mohammadinasab R Health Sci Rep. 2023; 6(11):e1670.

PMID: 37920661 PMC: 10618901. DOI: 10.1002/hsr2.1670.


From the origin of NASH to the future of metabolic fatty liver disease.

Geier A, Tiniakos D, Denk H, Trauner M Gut. 2021; .

PMID: 33632710 PMC: 8292567. DOI: 10.1136/gutjnl-2020-323202.


Weight management in obesity - past and present.

Haslam D Int J Clin Pract. 2016; 70(3):206-17.

PMID: 26811245 PMC: 4832440. DOI: 10.1111/ijcp.12771.


Management of obesity in the writings of Soranus of Ephesus and Caelius Aurelianus.

Papavramidou N, Christopoulou-Aletra H Obes Surg. 2008; 18(6):763-5.

PMID: 18386109 DOI: 10.1007/s11695-007-9362-1.


References
1.
Mason E, Ito C . Gastric bypass. Ann Surg. 1969; 170(3):329-39. PMC: 1387676. DOI: 10.1097/00000658-196909010-00003. View

2.
Deitel M . Overview of operations for morbid obesity. World J Surg. 1998; 22(9):913-8. DOI: 10.1007/s002689900494. View

3.
Rolls B, Bell E . Dietary approaches to the treatment of obesity. Med Clin North Am. 2000; 84(2):401-18, vi. DOI: 10.1016/s0025-7125(05)70228-5. View

4.
COHEN S . Avicenna on food aversions and dietary prescriptions. Allergy Proc. 1992; 13(4):199-203. DOI: 10.2500/108854192778817194. View

5.
. Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity. JAMA. 1996; 276(23):1907-15. DOI: 10.1001/jama.1996.03540230057036. View